MedixMedix Inc.331A東証スタンダードサービス業FY ending Mar 2026, consolidated, J-GAAP

Medix revenue and profit

Out of every ¥100 of sales, about ¥16 is left as operating profit. Revenue changed +2.3% from the prior year, operating profit -17.8%.

Five-year trend

Revenue¥4.26B
FY ending Mar 2024: ¥4.18B¥4.18BFY ending Mar 2025: ¥4.16B¥4.16BFY ending Mar 2026: ¥4.26B¥4.26BFY24FY25FY26
Operating income¥659.4M
FY ending Mar 2024: ¥801.6M¥801.6MFY ending Mar 2025: ¥802.6M¥802.6MFY ending Mar 2026: ¥659.4M¥659.4MFY24FY25FY26
Operating margin15.5%
FY ending Mar 2024: 19.2%19.2%FY ending Mar 2025: 19.3%19.3%FY ending Mar 2026: 15.5%15.5%FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin10.3%
Asset turnover0.55×
ROA5.7%
ROA5.7%
Financial leverage2.29×
ROE13.0%

Denominators: ending assets and ending equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin10.3%
2024: 11.7%11.7%2025: 19.3%19.3%2026: 10.3%10.3%242526
Asset turnover0.55×
2024: 0.71×0.71×2025: 0.66×0.66×2026: 0.55×0.55×242526
ROA5.7%
2024: 8.3%8.3%2025: 12.8%12.8%2026: 5.7%5.7%242526
Financial leverage2.29×
2024: 2.74×2.74×2025: 2.32×2.32×2026: 2.29×2.29×242526
ROE13.0%
2024: 22.7%22.7%2025: 29.6%29.6%2026: 13.0%13.0%242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202411.7%0.71×8.3%2.74×22.7%
202519.3%0.66×12.8%2.32×29.6%
202610.3%0.55×5.7%2.29×13.0%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue2.9%
2026: 2.9%2.9%26
PPE ÷ total assets1.6%
2026: 1.6%1.6%26
Goodwill ÷ parent equity9.1%
2026: 9.1%9.1%26
Goodwill balance¥306.6M
2026: ¥306.6M¥306.6M26

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Income statement (JPY millions)

ItemFY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue4,1804,1624,257
Cost of revenue442433555
Gross profit3,7383,7283,702
SG&A2,9362,9263,042
Operating income802803659
Pretax income788952662
Income tax299148227
Net income attributable to owners489804437
Operating margin19.2%19.3%15.5%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 53%
2%
8%
2%
Other assets 35%

Funding

Other liabilities 54%
Equity 46%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥2.78B¥3.77B¥4.06B
Total assets¥5.9B¥6.67B¥7.73B
Net assets¥2.16B¥3.27B¥3.56B
Share capital¥75.8M¥259.8M¥259.8M
Property, plant and equipment¥132.5M¥114.8M¥122.1M
Intangible assets excluding goodwill¥34.8M¥22.7M¥333.1M
Goodwill——¥306.6M
Investment securities¥27.1M¥27.1M¥166.9M
Current assets¥5.18B¥6.1B¥6.75B
Current liabilities¥3.13B¥2.83B¥3.08B
Long-term borrowings¥111M¥16M¥633.6M
Total liabilities¥3.75B¥3.4B¥4.17B
Non-controlling interests——¥126.9M
Equity attributable to owners of parent¥2.16B¥3.27B¥3.37B
Retained earnings¥2.02B¥2.76B¥3.09B
Treasury stock-¥16.2M-¥16.2M-¥204.9M

Sources

Show source documents (2)
  • EDINET (FSA Japan)

    有価証券報告書-第43期(2025/04/01-2026/03/31)

    ID S100YHLO2026-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第42期(2024/04/01-2025/03/31)

    ID S100W5702025-06-26Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.